So Ohta

715 total citations
18 papers, 600 citations indexed

About

So Ohta is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, So Ohta has authored 18 papers receiving a total of 600 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 9 papers in Radiology, Nuclear Medicine and Imaging and 6 papers in Immunology. Recurrent topics in So Ohta's work include Glycosylation and Glycoproteins Research (13 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immunotherapy and Immune Responses (3 papers). So Ohta is often cited by papers focused on Glycosylation and Glycoproteins Research (13 papers), Monoclonal and Polyclonal Antibodies Research (8 papers) and Immunotherapy and Immune Responses (3 papers). So Ohta collaborates with scholars based in Japan, Singapore and United Kingdom. So Ohta's co-authors include Nobuo Hanai, Kenya Shitara, Masako Wakitani, Takashi Nishimura, Kazuyasu Nakamura, Akito Natsume, Yukiko Shimizu, Hiroyuki Takamura, Mitsuo Satoh and Tomoaki Nakagawa and has published in prestigious journals such as Cancer Research, Journal of Controlled Release and International Journal of Cancer.

In The Last Decade

So Ohta

18 papers receiving 580 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
So Ohta Japan	14	295	259	244	168	70	18	600
Takashi Kagari Japan	12	276 0.9×	217 0.8×	364 1.5×	302 1.8×	10 0.1×	24	878
Fabian Richter Germany	13	213 0.7×	176 0.7×	130 0.5×	129 0.8×	23 0.3×	23	455
Jill E. Hutchcroft United States	12	367 1.2×	354 1.4×	810 3.3×	166 1.0×	17 0.2×	13	1.1k
Lanjuan Li China	6	523 1.8×	412 1.6×	356 1.5×	135 0.8×	8 0.1×	10	803
Anwar Murtaza United States	9	284 1.0×	258 1.0×	296 1.2×	153 0.9×	25 0.4×	13	596
Shiteng Duan United States	10	391 1.3×	82 0.3×	384 1.6×	58 0.3×	68 1.0×	14	665
Emily Capone Italy	16	352 1.2×	223 0.9×	143 0.6×	396 2.4×	12 0.2×	36	723
Daniela Achkova United Kingdom	9	303 1.0×	40 0.2×	368 1.5×	253 1.5×	14 0.2×	13	666
Miriana Moran United States	10	558 1.9×	79 0.3×	730 3.0×	137 0.8×	12 0.2×	10	1.0k
Stefania Martignone Italy	10	213 0.7×	184 0.7×	107 0.4×	224 1.3×	7 0.1×	17	479

Countries citing papers authored by So Ohta

Since Specialization

Citations

This map shows the geographic impact of So Ohta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by So Ohta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites So Ohta more than expected).

Fields of papers citing papers by So Ohta

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by So Ohta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by So Ohta. The network helps show where So Ohta may publish in the future.

Co-authorship network of co-authors of So Ohta

This figure shows the co-authorship network connecting the top 25 collaborators of So Ohta. A scholar is included among the top collaborators of So Ohta based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with So Ohta. So Ohta is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Suzuki, Masayo, et al.. (2010). Characterization and evaluation of the antitumour activity of a dual-targeting monoclonal antibody against claudin-3 and claudin-4.. PubMed. 30(11). 4555–62. 30 indexed citations

Suzuki, Masayo, Akiko Furuya, Yuzuru Abe, et al.. (2009). Therapeutic antitumor efficacy of monoclonal antibody against Claudin‐4 for pancreatic and ovarian cancers. Cancer Science. 100(9). 1623–1630. 69 indexed citations

Natsume, Akito, Hiroyuki Takamura, Tomoaki Nakagawa, et al.. (2008). Engineered Antibodies of IgG1/IgG3 Mixed Isotype with Enhanced Cytotoxic Activities. Cancer Research. 68(10). 3863–3872. 148 indexed citations

Ando, Hiroshi, Masako Wakitani, Takashi Sato, et al.. (2008). Mouse-Human Chimeric Anti-Tn IgG1 Induced Anti-tumor Activity against Jurkat Cells in Vitro and in Vivo. Biological and Pharmaceutical Bulletin. 31(9). 1739–1744. 32 indexed citations

Suzawa, Toshiyuki, Satoru Nagamura, Hiromitsu Saito, et al.. (2000). Synthesis of a novel duocarmycin derivative DU-257 and its application to immunoconjugate using poly(ethylene glycol)-dipeptidyl linker capable of tumor specific activation. Bioorganic & Medicinal Chemistry. 8(8). 2175–2184. 24 indexed citations

Ohta, So, Kenya Shitara, Masahide Fujita, et al.. (2000). Therapeutic potential of chimeric anti-(ganglioside GD3) antibody KM871: antitumor activity in xenograft model of melanoma and effector function analysis. Cancer Immunology Immunotherapy. 49(4-5). 253–258. 12 indexed citations

Suzawa, Toshiyuki, Satoru Nagamura, Hiromitsu Saito, et al.. (2000). Synthesis and HPLC analysis of enzymatically cleavable linker consisting of poly(ethylene glycol) and dipeptide for the development of immunoconjugate. Journal of Controlled Release. 69(1). 27–41. 18 indexed citations

Ohta, So, Nobuo Hanai, Kazuya Fukuoka, et al.. (1999). Effect of a chimeric anti-ganglioside GM2 antibody on ganglioside GM2-expressing human solid tumorsIn vivo. International Journal of Cancer. 82(5). 759–764. 15 indexed citations

Shinoda, Katsumi, Kenya Shitara, Yuko Yoshihara, et al.. (1998). Panosialins, inhibitors of an α1,3-fucosyltransferase Fuc-TVII, suppress the expression of selectin ligands on U937 cells. Glycoconjugate Journal. 15(11). 1079–1083. 12 indexed citations

10.

Nishio, Kazuto, et al.. (1996). Reversal of adriamycin resistance with chimeric anti-ganglioside GM2 antibody. International Journal of Cancer. 67(5). 676–680. 14 indexed citations

11.

Miki, Ichiro, So Ohta, Nobuo Hanai, et al.. (1996). Histamine Enhanced the TNF-α-Induced Expression of E-Selectin and ICAM-1 on Vascular Endothelial Cells. Cellular Immunology. 171(2). 285–288. 63 indexed citations

12.

Ohta, So, Hideo Tsukamoto, Kazuhito Watanabe, et al.. (1995). Tumor-associated glycoantigen, sialyl Lewisa as a target for bispecific antibody-directed adoptive tumor immunotherapy. Immunology Letters. 44(1). 35–40. 17 indexed citations

13.

Shitara, Kenya, et al.. (1994). Immunoglobulin class switch of anti-ganglioside monoclonal antibody from IgM to IgG. Journal of Immunological Methods. 169(1). 83–92. 8 indexed citations

14.

Ohta, So, Nobuo Hanai, Sonoko Habu, & Takashi Nishimura. (1993). Expression of Sialyl Lewisx Antigen on Human T Cells. Cellular Immunology. 151(2). 491–497. 13 indexed citations

15.

Ohta, So, et al.. (1993). Antitumor effects of a novel monoclonal antibody with high binding affinity to ganglioside GD3. Cancer Immunology Immunotherapy. 36(4). 260–266. 29 indexed citations

16.

Shitara, Kenya, Yoshihisa Kuwana, Kazuyasu Nakamura, et al.. (1993). A mouse/human chimeric anti-(ganglioside GD3) antibody with enhanced antitumor activities. Cancer Immunology Immunotherapy. 36(6). 373–380. 30 indexed citations

17.

Nishimura, Takashi, So Ohta, Naoko Sato, et al.. (1987). Combination tumor‐immunotherapy with recombinant tumor necrosis factor and recombinant interleukin 2 in mice. International Journal of Cancer. 40(2). 255–261. 45 indexed citations

18.

Nishimura, Takashi, Hideki Yagi, Naoko Sato, So Ohta, & Yoshiyuki Hashimoto. (1987). The role of lymphokine-activated cell-associated antigen. Cellular Immunology. 107(1). 32–39. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact